FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Potassium Chloride Injection
Status: Currently in Shortage
»Date first posted: 05/15/2012
»Therapeutic Categories: Gastroenterology; Endocrinology/Metabolism; Pediatric; Total Parenteral Nutrition

Expand all

B. Braun Medical Inc. (Reverified 07/24/2018)

Company Contact Information:
800-227-2862

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
250mL Potassium Chloride Injection Concentrate (2 mEq K/mL)(NDC 0264-1940-20) Product on allocation to contracted customers Manufacturing delays

Baxter Healthcare (Reverified 07/26/2018)

Company Contact Information:
888-229-0001

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
10 mEq/100 mL in sterile water (NDC 00338-0709-48) On allocation Other
20 mEq/100 mL in sterile water (NDC 00338-0705-48) On allocation Other
40 mEq/100 mL in sterile water (NDC 00338-0703-48) On allocation Other
20 mEq/50 mL in sterile water (NDC 00338-0703-41) On allocation Other
10 mEq/50 mL in sterile water (NDC 00338-0705-41) On allocation Other
20 mEq/1000 mL in lactated ringers and dextrose 5% (NDC 00338-0811-04) Available Other
20 mEq/1000 mL in 5% dextrose and 0.9% sodium chloride (NDC 00338-0803-04) Available Other
20 mEq/1000 mL in 0.9% sodium chloride (NDC 00338-0691-04) Available Other
40 mEq/1000 mL in 5% dextrose and 0.45% sodium chloride (NDC 00338-0675-04) Available Other
20 mEq/1000 mL in 5% dextrose (NDC 00338-0683-04) Available Other
40 mEq/1000 mL in 0.9% sodium chloride (NDC 00338-0695-04) Available Other
20 mEq/1000 mL in 5% dextrose and 0.45% sodium chloride (NDC 00338-0671-04) Available Other
20 mEq/L in 5% dextrose and 0.45% sodium chloride, 500 mL (NDC 00338-0671-03) Available Other
20 mEq/1000 mL in 0.45% sodium chloride (NDC 00338-0704-34) Available Other
40 mEq/1000 mL in 5% dextrose and 0.9% sodium chloride (NDC 00338-0807-04) Available Other
20 mEq/L in 5% dextrose and 0.2% sodium chloride, 500 mL (NDC 00338-0663-03) Available Other
20 mEq/1000 mL in 5% dextrose and 0.2% sodium chloride (NDC 00338-0663-04) Available Other
10 mEq/1000 mL in 5% dextrose and 0.45% sodium chloride (NDC 00338-0669-04) Available Other
30 mEq/1000 mL in 5% dextrose and 0.45% sodium chloride (NDC 00338-0673-04) Available Other

Fresenius Kabi USA, LLC (Revised 07/26/2018)

Company Contact Information:
888-386-1300

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
2 mEq/mL, 5 mL vials, (NDC 63323-0965-05) Backordered. Next release date anticipated August 2018. Manufacturing delay
2 mEq/mL, 10 mL vials, (NDC 63323-0965-10) Backordered. Next release date not available at this time. Check wholesalers for inventory Manufacturing delay
2 mEq/mL, 15 mL vials, (NDC 63323-0965-15) Unavailable
2 mEq/mL, 20 mL vials, (NDC 63323-0965-20) Available Check wholesalers for inventory Manufacturing delay
2 mEq/mL, 30 mL vials, (NDC 63323-0967-30) Backordered. Next release date not available at this time. Check wholesalers for inventory Manufacturing delay

Hospira, Inc. (Revised 08/08/2018)

Company Contact Information:
844-646-4398

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
10 mEq/5 mL (2 mEq/mL); Single Dose Glass Fliptop Vial (NDC 00409-6635-01) Limited Supply Available. Next Delivery: August 2018; Estimated Recovery: September 2018 Demand increase for the drug
2 mEq/mL; 15 mL vial (NDC 00409-6636-01) Discontinuation of the manufacture of the drug Discontinuation of the manufacture of the drug
20 mEq/10 mL (2 mEq/mL); Single Dose Plastic Fliptop Vial (NDC 00409-6651-06) Next Delivery: August 2018; Estimated Recovery: November 2018 Demand increase for the drug
40 mEq/20 mL (2 mEq/mL); Single Dose Plastic Fliptop Vial (NDC 00409-6653-05) Next Delivery: August 2018; Estimated Recovery: October 2018 Demand increase for the drug

ICU Medical, Inc. (Revised 08/09/2018)

Company Contact Information:
877-946-7747

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
10 mEq/100 mL (NDC 0409-7074-26) Product on allocation Available. ICU Medical acquired these products from Hospira, a Pfizer company. For questions or inquiries regarding these Hospira labeled products, please contact ICU Medical. Other
10 mEq/50 mL (NDC 0409-7075-14) Next delivery: Early September Estimated recovery: Early September Please check with your wholesaler for available inventory. ICU Medical acquired these products from Hospira, a Pfizer company. For questions or inquiries regarding these Hospira labeled products, please contact ICU Medical. Demand increase for the drug
20 mEq/100 mL, (NDC 0409-7075-26) Next delivery: Mid August Estimated recovery: Early October Please check with your wholesaler for available inventory. ICU Medical acquired these products from Hospira, a Pfizer company. For questions or inquiries regarding these Hospira labeled products, please contact ICU Medical. Demand increase for the drug
20 mEq/50 mL (NDC 0409-7077-14) Product on allocation Available. ICU Medical acquired these products from Hospira, a Pfizer company. For questions or inquiries regarding these Hospira labeled products, please contact ICU Medical. Other
40 mEq/100 mL (NDC 0409-7077-26) Product on allocation Available. ICU Medical acquired these products from Hospira, a Pfizer company. For questions or inquiries regarding these Hospira labeled products, please contact ICU Medical. Other
40 mEq/1000 mL (NDC 0409-7116-09) Product on allocation Available. ICU Medical acquired these products from Hospira, a Pfizer company. For questions or inquiries regarding these Hospira labeled products, please contact ICU Medical. Other
20 mEq/1000 mL in 0.9% NaCl (NDC 0409-7115-09) Next delivery: Early October Estimated recovery: Early October Please check with your wholesaler for available inventory. ICU Medical acquired these products from Hospira, a Pfizer company. For questions or inquiries regarding these Hospira labeled products, please contact ICU Medical. Demand increase for the drug
20 mEq/1000 mL in 5% dextrose (NDC 0409-7905-09) Product on allocation Available. ICU Medical acquired these products from Hospira, a Pfizer company. For questions or inquiries regarding these Hospira labeled products, please contact ICU Medical. Other
20 mEq/1000 mL in 5% Dex/Lact Ringers (NDC 0409-7111-09) Product on allocation Available. ICU Medical acquired these products from Hospira, a Pfizer company. For questions or inquiries regarding these Hospira labeled products, please contact ICU Medical. Other
10 mEq/500 mL in 5% dex & 0.225% NaCl (NDC 0409-7901-03) Product is being discontinued Shortage per Manufacturer: Manufacturing Delay. ICU Medical acquired these products from Hospira, a Pfizer company. For questions or inquiries regarding these Hospira labeled products, please contact ICU Medical. Discontinuation of the manufacture of the drug
10 mEq/ 500 mL in 5% dex 0.45% NaCl (NDC 0409-7902-03) Product on allocation Available. ICU Medical acquired these products from Hospira, a Pfizer company. For questions or inquiries regarding these Hospira labeled products, please contact ICU Medical. Other
20 mEq/1000 mL in 5% dex& 0.225% NaCl (NDC 0409-7901-09) Product on allocation Available. ICU Medical acquired these products from Hospira, a Pfizer company. For questions or inquiries regarding these Hospira labeled products, please contact ICU Medical. Other
20 mEq/1000 mL in 5% dex& 0.45% NaCl (NDC 0409-7902-09) Product on allocation Available. ICU Medical acquired these products from Hospira, a Pfizer company. For questions or inquiries regarding these Hospira labeled products, please contact ICU Medical. Other
30 mEq/1000 mL in 5% dex& 0.45% NaCl (NDC 0409-7903-09) Product on allocation Available. ICU Medical acquired these products from Hospira, a Pfizer company. For questions or inquiries regarding these Hospira labeled products, please contact ICU Medical. Other
40 mEq/1000 mL in 5% dex& 0.45% NaCl (NDC 0409-7904-09) Product on allocation Available. ICU Medical acquired these products from Hospira, a Pfizer company. For questions or inquiries regarding these Hospira labeled products, please contact ICU Medical. Other
10 mEq/1000 mL in 5% dex & 0.45% NaCl (NDC 0409-7993-09) Product on allocation Available. ICU Medical acquired these products from Hospira, a Pfizer company. For questions or inquiries regarding these Hospira labeled products, please contact ICU Medical. Other
20 mEq/1000 mL in 5% dex & 0.9% NaCl (NDC 0409-7107-09) Product on allocation Available. ICU Medical acquired these products from Hospira, a Pfizer company. For questions or inquiries regarding these Hospira labeled products, please contact ICU Medical. Other
40 mEq/1000 mL in 5% dex & 0.9% NaCl (NDC 0409-7109-09) Product on allocation Available. ICU Medical acquired these products from Hospira, a Pfizer company. For questions or inquiries regarding these Hospira labeled products, please contact ICU Medical. Other

Industria Farmaceutica Galenica Senese S.r.l. (Galenica)-distributed by Athenex Pharmaceutical Division, LLC (New 08/01/2018)

Company Contact Information:
855-273-0154

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Potassium Chloride Injection, Concentrate, 2 mEq/mL; 10mL ampules; 10 ampules per carton (NDC 72439-500-10) Available Athenex Pharmaceutical Division, LLC (Athenex)in conjunction with FDA has initiated temporary importation of Potassium Chloride Injection, Concentrate, 2 mEq/mL manufactured and marketed in Italy by Industria Farmaceutica Galenica Senese S.r.l. (Galenica)- into the U.S. market to address drug shortages.

Dear Healthcare Provider Letter

Available

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English